Actavis completes $1.1bn Furiex acquisition

03-07-2014

Actavis completes $1.1bn Furiex acquisition

Alexeysun / Shutterstock.com

Actavis’s newly-acquired subsidiary Forest Laboratories has bought drug development company Furiex Pharmaceuticals for $1.1 billion.


Actavis, Forest, Furiex, eluxadoline, mergers and acquisitions

More on this story

Actavis to buy Forest for $25 billion
21-02-2014

LSIPR